Location History:
- Fullinsdorf, CH (1997 - 2006)
- Füllinsdorf, CH (2006 - 2015)
Company Filing History:
3 out of 37 
1 out of 576 
Years Active: 1997-2015
Title: The Innovations of Denis Monard
Introduction
Denis Monard is a notable inventor based in Füllinsdorf, Switzerland. He has made significant contributions to the field of biomedical research, holding a total of three patents. His work focuses on innovative methods that have the potential to impact therapeutic approaches in medicine.
Latest Patents
One of his latest patents is titled "Use of protease nexin 1 inhibitors to reduce metastasis." This invention relates to a method of inhibiting metastasis through the administration of an inhibitor of protease nexin-1 (PN-1). The method is characterized by the administration of the inhibitor at a therapeutic dosage that does not completely inhibit the expression and/or activity of PN-1. Another significant patent is "Protease-activated receptor (PAR) modulator assays." This patent provides a method for identifying a PAR cleaving molecule, which involves several steps, including providing an immobilized PAR cleavage peptide linked to a reporter molecule and detecting the release of the reporter molecule.
Career Highlights
Denis Monard has worked with prestigious organizations, including the Novartis Research Foundation and the Friedrich Miescher Institute for Biomedical Research. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the biomedical field.
Collaborations
Throughout his career, Denis has collaborated with esteemed colleagues such as Bérengère Fayard and Ludger Altrogge. These collaborations have further enriched his research and innovation efforts.
Conclusion
Denis Monard's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic methods.